| |
Article Title |
Author(s) |
Type (Status) |
Available Online |
|
Airway obstruction lability helps distinguish levels of disease activity in asthma
DOI: 10.1016/j.rmed.2011.12.013
Summary: Classifying disease activity in asthma relies on clinical and physiological variables, but these variables do not capture all aspects of asthma that distinguish levels of disease activity. We...
|
Steven Greenberg,
Nancy Liu,
Amarjot Kaur,
Mani Lakshminarayanan,
Yijie Zhou,
Linda M. Nelsen,
Steven S. Smugar,
Gertrude Noonan,
Theodore F. Reiss,
Barbara A. Knorr
et al.
|
Full-length article
(In Press Corrected Proof)
|
02 February 2012 |
|
Ethnic and racial differences in the presence of idiopathic pulmonary fibrosis at death
DOI: 10.1016/j.rmed.2012.01.002
Summary: Background: In studies of idiopathic pulmonary fibrosis (IPF), whites makeup the vast majority of subjects. Whether ethnic/racial differences in idiopathic pulmonary fibrosis occur in the gen...
|
Jeffrey J. Swigris,
Amy L. Olson,
Tristan J. Huie,
Evans R. Fernandez-Perez,
Joshua Solomon,
David Sprunger,
Kevin K. Brown
et al.
|
Full-length article
(In Press Corrected Proof)
|
01 February 2012 |
|
HIV and asthma, is there an association?
DOI: 10.1016/j.rmed.2011.12.017
Summary: Objective: To evaluate whether asthma and airway hyper-responsiveness are associated with HIV infection. Methods: We reviewed the literature on HIV-associated pulmonary diseases, pulmonary sy...
|
Jessica A. Kynyk,
Jonathan P. Parsons,
Michael F. Para,
Susan L. Koletar,
Philip T. Diaz,
John G. Mastronarde
et al.
|
Review article
(In Press Corrected Proof)
|
30 January 2012 |
|
Rituximab therapy for refractory interstitial lung disease related to antisynthetase syndrome
DOI: 10.1016/j.rmed.2012.01.001
Summary: Objective: To report our experience using rituximab as therapy for refractory antisynthetase syndrome (ASS)-associated interstitial lung disease. Methods: We retrospectively evaluated the med...
|
I. Marie,
S. Dominique,
A. Janvresse,
H. Levesque,
J-F. Menard
et al.
|
Full-length article
(In Press Corrected Proof)
|
27 January 2012 |
|
Inhaler mishandling is very common in patients with chronic airflow obstruction and long-term home nebuliser use
DOI: 10.1016/j.rmed.2011.11.016
Summary: Inhalers and nebulisers are devices used for delivering aerosolised drugs in subjects with Chronic Airflow Obstruction (CAO). This multicentre, cross-sectional observational study was perform...
|
Andrea S. Melani,
PierAldo Canessa,
Isotta Coloretti,
Giuseppe DeAngelis,
Renato DeTullio,
Mario DelDonno,
Raffaela Giacobbe,
Ines Scarlato,
Antonella Serafini,
Natalino Barbato,
Adriano Vaghi,
Piersante Sestini
et al.
|
Full-length article
(In Press Corrected Proof)
|
25 January 2012 |
|
Impact of add-on pranlukast in stable asthma; the additive effect on peripheral airway inflammation
DOI: 10.1016/j.rmed.2011.12.014
Summary: Backgound: The importance of airway inflammation has been highlighted in the pathophysiology of asthma. Even in controlled asthmatics treated with inhaled corticosteroid (ICS), residual airwa...
|
Hideki Yasui,
Tomoyuki Fujisawa,
Naoki Inui,
Masato Kato,
Dai Hashimoto,
Noriyuki Enomoto,
Yutaro Nakamura,
Toshihiro Shirai,
Takafumi Suda,
Hirotoshi Nakamura,
Kingo Chida
et al.
|
Full-length article
(In Press Corrected Proof)
|
24 January 2012 |
|
Raised erythrocyte creatine in patients with pulmonary arterial hypertension – Evidence for subclinical hemolysis
DOI: 10.1016/j.rmed.2011.12.005
Summary: Background: Pulmonary arterial hypertension (PAH) has been associated with hemolytic conditions such as sickle cell disease but the possible role of hemolysis in the pathogenesis or pathophys...
|
Benjamin D. Fox,
Toshika Okumiya,
Liat Attas-Fox,
Michael Kassirer,
Yael Raviv,
Mordechai R. Kramer
et al.
|
Full-length article
(In Press Corrected Proof)
|
16 January 2012 |
|
Lung capillary blood volume and membrane diffusion in idiopathic interstitial pneumonia
DOI: 10.1016/j.rmed.2011.12.011
Summary: Rationale: Diffusing capacity of the lung for carbon monoxide (DLCO) is a good marker of disease severity in patients with idiopathic interstitial pneumonia (IIP). The combined diffusing capa...
|
Lidwine Wémeau-Stervinou,
Thierry Perez,
Colm Murphy,
Anne-Sophie Polge,
Benoît Wallaert
et al.
|
Full-length article
(In Press Corrected Proof)
|
06 January 2012 |
|
Chronic obstructive pulmonary disease and cancer risk: A Danish nationwide cohort study
DOI: 10.1016/j.rmed.2011.12.009
Summary: Introduction: Little is known about the risk of cancer in patients with chronic obstructive pulmonary disease (COPD), including which cancer sites are most affected. We examined the short- an...
|
Jette Brommann Kornum,
Claus Sværke,
Reimar Wernich Thomsen,
Peter Lange,
Henrik Toft Sørensen
et al.
|
Full-length article
(In Press Corrected Proof)
|
04 January 2012 |
|
S100A9 in BALF is a candidate biomarker of idiopathic pulmonary fibrosis
DOI: 10.1016/j.rmed.2011.12.010
Summary: Background: Idiopathic pulmonary fibrosis (IPF) is a specific form of chronic, progressive fibrosing interstitial pneumonia of unknown cause, and the prognosis remains poor. On the other hand...
|
Atsuko Hara,
Noriho Sakamoto,
Yuji Ishimatsu,
Tomoyuki Kakugawa,
Shota Nakashima,
Shintaro Hara,
Misato Adachi,
Hanako Fujita,
Hiroshi Mukae,
Shigeru Kohno
et al.
|
Full-length article
(In Press Corrected Proof)
|
03 January 2012 |
|
Have we underestimated the efficacy of pulmonary rehabilitation in improving mood?
DOI: 10.1016/j.rmed.2011.12.003
Summary: Background: Patients with COPD have a high prevalence of anxiety and depression. The efficacy of pulmonary rehabilitation (PR) in treating more severe anxiety and depression is unknown. The s...
|
S.L. Harrison,
N.J. Greening,
J.E.A. Williams,
M.D.L. Morgan,
M.C. Steiner,
S.J. Singh
et al.
|
Full-length article
(In Press Corrected Proof)
|
26 December 2011 |
|
AZD9668, a neutrophil elastase inhibitor, plus ongoing budesonide/formoterol in patients with COPD
DOI: 10.1016/j.rmed.2011.10.020
Summary: Background: Neutrophil elastase (NE) is implicated in chronic obstructive pulmonary disease (COPD). AZD9668 is a reversible and selective inhibitor of NE, well tolerated at doses of 60mg bid ...
|
Piotr Kuna,
Martin Jenkins,
Christopher D. O’Brien,
William A. Fahy
|
Full-length article
(In Press Corrected Proof)
|
26 December 2011 |
|
Lymphangiogenesis in COPD: Another link in the pathogenesis of the disease
DOI: 10.1016/j.rmed.2011.11.011
Summary: Background: New lymphatic vessels are associated with tissue injury and repair. Recent studies have shown increased lymphatic follicles formation in the lungs of COPD patients. We hypothesize...
|
Georgia Hardavella,
Eleni G. Tzortzaki,
Vasiliki Siozopoulou,
Petros Galanis,
Eleni Vlachaki,
Maria Avgousti,
Dimitrios Stefanou,
Nikolaos M. Siafakas
et al.
|
Full-length article
(In Press Corrected Proof)
|
08 December 2011 |
|
A better response in exercise capacity after pulmonary rehabilitation in more severe COPD patients
DOI: 10.1016/j.rmed.2011.11.008
Summary: Purpose: Pulmonary rehabilitation (PR) has positive effects on exercise capacity in Chronic Obstructive Pulmonary Disease (COPD). However, not all COPD patients benefit from PR to the same ex...
|
Wytske A. Altenburg,
Mathieu H.G. de Greef,
Nick H.T. ten Hacken,
Johan B. Wempe
|
Full-length article
(In Press Corrected Proof)
|
08 December 2011 |
|
Influence of inspiration level on bronchial lumen measurements with computed tomography
DOI: 10.1016/j.rmed.2011.11.013
Summary: Background: Bronchial dimensions measured in CT images generally do not take inspiration level into consideration. However, some studies showed that the bronchial membrane is distensible with...
|
M. Els Bakker,
Jan Stolk,
Johan H.C. Reiber,
Berend C. Stoel
|
Full-length article
(In Press Corrected Proof)
|
07 December 2011 |
|
Current and emerging medical treatments for non–small cell lung cancer: A primer for pulmonologists
DOI: 10.1016/j.rmed.2011.10.016
Summary: Pulmonary physicians commonly develop relationships with lung cancer patients through the evaluation and staging of the disease prior to the discussion of treatment options with oncologists. ...
|
Peter Mazzone,
Tarek Mekhail
|
Review article
(In Press Corrected Proof)
|
28 November 2011 |
|
Physical activity monitoring in COPD: Compliance and associations with clinical characteristics in a multicenter study
DOI: 10.1016/j.rmed.2011.10.022
Summary: Background: Little is known about COPD patients’ compliance with physical activity monitoring and how activity relates to disease characteristics in a multi-center setting. Methods: In a pros...
|
Benjamin Waschki,
Martijn A. Spruit,
Henrik Watz,
Paul S. Albert,
Dinesh Shrikrishna,
Miriam Groenen,
Cayley Smith,
William D.-C. Man,
Ruth Tal-Singer,
Lisa D. Edwards,
Peter M.A. Calverley,
Helgo Magnussen,
Michael I. Polkey,
Emiel F.M. Wouters
et al.
|
Full-length article
(In Press Corrected Proof)
|
28 November 2011 |
|
Strength training increases maximum working capacity in patients with COPD – Randomized clinical trial comparing three training modalities
DOI: 10.1016/j.rmed.2011.11.005
Summary: Background and objective: Skeletal muscle dysfunction contributes to exercise limitation in patients with chronic obstructive pulmonary disease (COPD). Strength training increases muscle stre...
|
Karin Vonbank,
Barbara Strasser,
Jerzy Mondrzyk,
Beatrice A. Marzluf,
Bernhard Richter,
Stephen Losch,
Herbert Nell,
Ventzislav Petkov,
Paul Haber
et al.
|
Full-length article
(In Press Corrected Proof)
|
28 November 2011 |
|
All Danish first-time COPD hospitalisations 2002–2008: Incidence, outcome, patients, and care
DOI: 10.1016/j.rmed.2011.11.001
Summary: Objective: This study aimed to investigate trends in first-time hospitalisations with chronic obstructive pulmonary disease (COPD) in a publicly financed healthcare system during the period f...
|
Jesper Lykkegaard,
Jens Søndergaard,
Jakob Kragstrup,
Jesper Rømhild Davidsen,
Thomas Knudsen,
Morten Andersen
et al.
|
Full-length article
(In Press Corrected Proof)
|
24 November 2011 |
|
Cause-specific mortality adjudication in the UPLIFT® COPD trial: Findings and recommendations
DOI: 10.1016/j.rmed.2011.10.009
Summary: Mortality is an important endpoint in chronic obstructive pulmonary disease (COPD) trials, although accurately determining cause of death is difficult. In the Understanding the Potential Long...
|
Lorcan P. McGarvey,
Sheldon Magder,
Deborah Burkhart,
Steven Kesten,
Dacheng Liu,
Raymond C. Manuel,
Denis E. Niewoehner
et al.
|
Full-length article
(In Press Corrected Proof)
|
21 November 2011 |
|
Direct medical costs of COPD – An excess cost approach based on two population-based studies
DOI: 10.1016/j.rmed.2011.10.013
Summary: Aim: While it is known that severe COPD has substantial economic consequences, evidence on resource use and costs in mild disease is scarce. The objective of this study was to investigate exc...
|
Petra Menn,
Joachim Heinrich,
Rudolf M. Huber,
Rudolf A. Jörres,
Jürgen John,
Stefan Karrasch,
Annette Peters,
Holger Schulz,
Rolf Holle,
for the KORA Study Group
et al.
|
Full-length article
(In Press Corrected Proof)
|
21 November 2011 |
|
Efficacy and safety of Flutiform compared with individual fluticasone and formoterol reference products
DOI: 10.1016/j.rmed.2011.06.002
The paper by Bodzenta-Lukaszyk et al. published recently in Respiratory Medicine investigated the two indications of Flutiform: substitution treatment in patients already controlled with the individua...
|
Alfredo García Arieta
|
Correspondence
(In Press Corrected Proof)
|
23 June 2011 |
|
WITHDRAWN: A case of acute pneumonitis associated with leflunomide treatment
DOI: 10.1016/j.rmed.2005.01.010
This article has been withdrawn at the request of the author(s) and/or editor. The Publisher apologizes for any inconvenience this may cause. The full Elsevier Policy on Article Withdrawal can be foun...
|
Gareth Collier,
P. Flood-Page
|
Retraction
(In Press Corrected Proof)
|
01 March 2005 |
|
WITHDRAWN: Endogenous lipoid pneumonia
DOI: 10.1016/j.rmed.2004.12.011
This article has been withdrawn at the request of the author(s) and/or editor. The Publisher apologizes for any inconvenience this may cause. The full Elsevier Policy on Article Withdrawal can be foun...
|
D.G. Popov,
N.I. Doncheva,
V.I. Vlasov
|
Retraction
(In Press Corrected Proof)
|
02 February 2005 |